InvestSMART

Nexsen Limited (ASX:NXN)

ALERT: Price-sensitive ASX Announcement for NXN
Current share price for NXN : $0.240 0.055 (29.73%)+
Announcement
Release
13 May 2026 8:55AM
Price at Release
$0.185
Full Release
download
Summary
Nexsen Limited has announced a strategic partnership with GHK Hospital Limited, a subsidiary of IHH Healthcare Berhad, to facilitate the clinical validation and commercialization of Nexsen’s rapid point-of-care diagnostic platform in Asia. This collaboration provides Nexsen with access to GHK's 500-bed hospital in Hong Kong and the broader IHH network, allowing for the assessment of its diagnostic products in real-world settings. The partnership represents a significant step in Nexsen's Asia-Pacific strategy, aiming to enhance healthcare outcomes through innovative diagnostics. Nexsen continues to develop its platform with the support of grants and partnerships, reinforcing its commitment to improving diagnostic processes in critical healthcare areas.
Key Points
  • Nexsen Limited partners with GHK Hospital Limited for diagnostics.
  • Access to a 500-bed multi-specialty hospital in Hong Kong.
  • Collaborates with IHH Healthcare’s extensive network.
  • Facilitates clinical validation and potential adoption pathways.
  • Nexsen’s diagnostics address significant unmet clinical needs.
  • Partnership enhances Nexsen's Asia-Pacific strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.